Double HPV infection in African cervical cancer detected by polymerase chain reaction

dc.contributor.author	Rogo Khama O.
dc.contributor.author	Evander, M
dc.contributor.author	Bjersing, L
dc.contributor.author	Stendahl, U
dc.contributor.author	Wadell, G
dc.date.accessioned	2013-06-07T06:23:54Z
dc.date.available	2013-06-07T06:23:54Z
dc.date.issued	1991-02
dc.identifier.citation	Anticancer Res. 1991 Jan-Feb;11(1):169-74.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/1850214
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/29673
dc.description.abstract	Biopsy samples from 13 Kenyan patients with squamous cell carcinoma of the cervix were analysed for the presence of type specific HPV DNA by polymerase chain reaction (PCR). HPV 16 was confirmed in 11 (85%) and HPV 18 in 9 (69%) samples. HPV 6 DNA was detectable in only 3 (23%) samples and no HPV 33 was found. Infection with either HpV16 or 18 was seen in 12 (92%) and infection with both in 8 (62%) cases. The prevalence of double infection found is higher than in previous reports. The significance of this and possible effects of parity on cervical neoplastic changes are discussed.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi.	en
dc.title	Double HPV infection in African cervical cancer detected by polymerase chain reaction	en
dc.type	Article	en
local.publisher	Department of Obstetrics and Gynecology, University of Nairobi, Kenya	en